Alphatec Receives FDA Approval For Solus Reports Jefferies

Alphatec Holdings ATEC has been granted FDA approval for Solus, an anterior interbody fusion device produced by the company, says Jefferies. In its report, Jefferies writes, “The approval of Solus gives ATEC a unique entrant into the $350mn US market for standalone ALIF devices. It is one of the more interesting products in the company's portfolio and provides additional support to current forecasts.” Jefferies maintains its Buy rating and a price target of $4 on the stock. ATEC closed yesterday at $2.88.